Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Human umbilical cord mesenchymal stem cells (Golden Meditech)
- Development stage
- Phase 1
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intrathecal, Inhalation, Intraarticular, Intranasal, Intramyocardial, Local Injection
01
Overview
Human umbilical cord mesenchymal stem cells (UC-MSCs) are multipotent cells derived from umbilical cord tissue with significant self-renewal and multi-lineage differentiation properties. They possess several therapeutic advantages including immunomodulatory effects, low immunogenicity, and paracrine actions. UC-MSCs can differentiate into various cell types including neural, bone, cartilage, and fat cells, making them valuable for tissue repair and regeneration. They secrete bioactive molecules such as cytokines, growth factors, and extracellular vesicles that modulate the local environment and stimulate the body's repair processes. UC-MSCs are being investigated for treating various conditions including neurodegenerative diseases, pulmonary disorders, autoimmune conditions, and inflammatory diseases.
- Other names
- Umbilical cord-derived mesenchymal stem cellsUmbilical cord tissue-derived mesenchymal stem cellsUmbilical cord Wharton's jelly-derived mesenchymal stem cellsUCWJ-MSCs
Beyond the preview
Go deeper on Human umbilical cord mesenchymal stem cells (Golden Meditech).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Human umbilical cord mesenchymal stem cells (Golden Meditech).